Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: Long-term maspin expression efficiently suppresses tumor growth

Masami Watanabe, Yasutomo Nasu, Yuji Kashiwakura, Norihiro Kusumi, Kenji Tamayose, Atsushi Nagai, Tetsuo Sasano, Takashi Shimada, Hiroyuki Daida, Hiromi Kumon

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Maspin is a member of the serine protease inhibitors and the maspin gene, a tumor suppressor gene, is down-regulated in a large fraction of prostate cancers. We evaluated the use of adeno-associated virus (AAV, serotype 2) vector encoding maspin as a means for in vivo gene therapy for human prostate cancer. TUNEL assay of subcutaneously formed LNCaP or DU145 tumors in nude mice showed that intratumoral AAV-mediated maspin expression significantly upregulated the number of apoptotic cells compared with AAV-LacZ treatment. Immunofluorescence double staining for maspin protein and apoptosis in LNCaP tumors showed that the percentage of apoptotic cells in AAV-maspin-mediated maspin-expressing cells was significantly high compared with that in AAV-GFP-mediated GFP-expressing cells. Moreover, significantly fewer CD31-positive microvessels were observed in AAV-maspin-treated tumors compared with the control tumors. These therapeutic responses were highly correlated to persistent maspin expression in tumors, confirmed by Western blot analysis until at least day 56 after treatment. Finally, intratumoral delivery of AAV-maspin significantly suppressed growth of LNCaP and DU145 tumors and improved survival of mice. We conclude that AAV-mediated prolonged maspin expression efficiently suppresses human prostate tumor growth in vivo by apoptosis induction and inhibition of angiogenesis.

Original languageEnglish
Pages (from-to)699-710
Number of pages12
JournalHuman Gene Therapy
Volume16
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Dependovirus
Neoplasm Genes
Genetic Therapy
Prostatic Neoplasms
Growth
Neoplasms
SERPIN-B5
Apoptosis
Serine Proteinase Inhibitors
In Situ Nick-End Labeling
Microvessels
Tumor Suppressor Genes
Nude Mice
Fluorescent Antibody Technique
Prostate
Therapeutics
Cell Count
Western Blotting
Staining and Labeling

ASJC Scopus subject areas

  • Genetics

Cite this

Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy : Long-term maspin expression efficiently suppresses tumor growth. / Watanabe, Masami; Nasu, Yasutomo; Kashiwakura, Yuji; Kusumi, Norihiro; Tamayose, Kenji; Nagai, Atsushi; Sasano, Tetsuo; Shimada, Takashi; Daida, Hiroyuki; Kumon, Hiromi.

In: Human Gene Therapy, Vol. 16, No. 6, 06.2005, p. 699-710.

Research output: Contribution to journalArticle

Watanabe, Masami ; Nasu, Yasutomo ; Kashiwakura, Yuji ; Kusumi, Norihiro ; Tamayose, Kenji ; Nagai, Atsushi ; Sasano, Tetsuo ; Shimada, Takashi ; Daida, Hiroyuki ; Kumon, Hiromi. / Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy : Long-term maspin expression efficiently suppresses tumor growth. In: Human Gene Therapy. 2005 ; Vol. 16, No. 6. pp. 699-710.
@article{4cb6ff4460ed45cd90c2c31e430d0d19,
title = "Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: Long-term maspin expression efficiently suppresses tumor growth",
abstract = "Maspin is a member of the serine protease inhibitors and the maspin gene, a tumor suppressor gene, is down-regulated in a large fraction of prostate cancers. We evaluated the use of adeno-associated virus (AAV, serotype 2) vector encoding maspin as a means for in vivo gene therapy for human prostate cancer. TUNEL assay of subcutaneously formed LNCaP or DU145 tumors in nude mice showed that intratumoral AAV-mediated maspin expression significantly upregulated the number of apoptotic cells compared with AAV-LacZ treatment. Immunofluorescence double staining for maspin protein and apoptosis in LNCaP tumors showed that the percentage of apoptotic cells in AAV-maspin-mediated maspin-expressing cells was significantly high compared with that in AAV-GFP-mediated GFP-expressing cells. Moreover, significantly fewer CD31-positive microvessels were observed in AAV-maspin-treated tumors compared with the control tumors. These therapeutic responses were highly correlated to persistent maspin expression in tumors, confirmed by Western blot analysis until at least day 56 after treatment. Finally, intratumoral delivery of AAV-maspin significantly suppressed growth of LNCaP and DU145 tumors and improved survival of mice. We conclude that AAV-mediated prolonged maspin expression efficiently suppresses human prostate tumor growth in vivo by apoptosis induction and inhibition of angiogenesis.",
author = "Masami Watanabe and Yasutomo Nasu and Yuji Kashiwakura and Norihiro Kusumi and Kenji Tamayose and Atsushi Nagai and Tetsuo Sasano and Takashi Shimada and Hiroyuki Daida and Hiromi Kumon",
year = "2005",
month = "6",
doi = "10.1089/hum.2005.16.699",
language = "English",
volume = "16",
pages = "699--710",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy

T2 - Long-term maspin expression efficiently suppresses tumor growth

AU - Watanabe, Masami

AU - Nasu, Yasutomo

AU - Kashiwakura, Yuji

AU - Kusumi, Norihiro

AU - Tamayose, Kenji

AU - Nagai, Atsushi

AU - Sasano, Tetsuo

AU - Shimada, Takashi

AU - Daida, Hiroyuki

AU - Kumon, Hiromi

PY - 2005/6

Y1 - 2005/6

N2 - Maspin is a member of the serine protease inhibitors and the maspin gene, a tumor suppressor gene, is down-regulated in a large fraction of prostate cancers. We evaluated the use of adeno-associated virus (AAV, serotype 2) vector encoding maspin as a means for in vivo gene therapy for human prostate cancer. TUNEL assay of subcutaneously formed LNCaP or DU145 tumors in nude mice showed that intratumoral AAV-mediated maspin expression significantly upregulated the number of apoptotic cells compared with AAV-LacZ treatment. Immunofluorescence double staining for maspin protein and apoptosis in LNCaP tumors showed that the percentage of apoptotic cells in AAV-maspin-mediated maspin-expressing cells was significantly high compared with that in AAV-GFP-mediated GFP-expressing cells. Moreover, significantly fewer CD31-positive microvessels were observed in AAV-maspin-treated tumors compared with the control tumors. These therapeutic responses were highly correlated to persistent maspin expression in tumors, confirmed by Western blot analysis until at least day 56 after treatment. Finally, intratumoral delivery of AAV-maspin significantly suppressed growth of LNCaP and DU145 tumors and improved survival of mice. We conclude that AAV-mediated prolonged maspin expression efficiently suppresses human prostate tumor growth in vivo by apoptosis induction and inhibition of angiogenesis.

AB - Maspin is a member of the serine protease inhibitors and the maspin gene, a tumor suppressor gene, is down-regulated in a large fraction of prostate cancers. We evaluated the use of adeno-associated virus (AAV, serotype 2) vector encoding maspin as a means for in vivo gene therapy for human prostate cancer. TUNEL assay of subcutaneously formed LNCaP or DU145 tumors in nude mice showed that intratumoral AAV-mediated maspin expression significantly upregulated the number of apoptotic cells compared with AAV-LacZ treatment. Immunofluorescence double staining for maspin protein and apoptosis in LNCaP tumors showed that the percentage of apoptotic cells in AAV-maspin-mediated maspin-expressing cells was significantly high compared with that in AAV-GFP-mediated GFP-expressing cells. Moreover, significantly fewer CD31-positive microvessels were observed in AAV-maspin-treated tumors compared with the control tumors. These therapeutic responses were highly correlated to persistent maspin expression in tumors, confirmed by Western blot analysis until at least day 56 after treatment. Finally, intratumoral delivery of AAV-maspin significantly suppressed growth of LNCaP and DU145 tumors and improved survival of mice. We conclude that AAV-mediated prolonged maspin expression efficiently suppresses human prostate tumor growth in vivo by apoptosis induction and inhibition of angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=20844433717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20844433717&partnerID=8YFLogxK

U2 - 10.1089/hum.2005.16.699

DO - 10.1089/hum.2005.16.699

M3 - Article

C2 - 15960601

AN - SCOPUS:20844433717

VL - 16

SP - 699

EP - 710

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -